This news is delayed by 15 minutes, sign up now to get live news & full features.
CRNX CRINETICS PHARMACEUTICALS INC
+ add to watchlist
$50.49
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
Mkt Cap: $4.75B
52 Week High: $56.53
P/E: -16.43
52 Week Low: $24.10
Dividend: $0.00
Shares Outstanding: 94.18M